RASIO
  • Home
  • Team
  • News
  • Contact

NEWS

National Foundation for Cancer Research Launches Partnership with Rasio Therapeutics

11/25/2019

 
NFCR commits $1 million in financing to Rasio Therapeutics to develop treatments targeting cancers with limited treatment options

November 25, 2019, Baltimore, MD – Rasio Therapeutics, Inc., a biopharmaceutical company that develops novel medicines using cutting-edge computer-aided drug design technology, today announced the launch of a formal partnership with the National Foundation for Cancer Research (NFCR). 


Read More

Todd Chappell  Appointed CEO of Rasio Therapeutics

11/13/2019

 
Chappell is a 20-year veteran of the biopharma industry with experience running multiple drug development programs from discovery stage through to clinical trials

​
November 14, 2019, Baltimore, MD – Rasio Therapeutics, Inc., a biopharmaceutical company that develops novel medicines using cutting-edge computer-aided drug design technology, today announced the appointment of Todd Chappell, a veteran medtech and pharmaceutical industry executive, as the company’s CEO.

Read More
Powered by Create your own unique website with customizable templates.
  • Home
  • Team
  • News
  • Contact